| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |